These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 12722160)

  • 21. [Challenges in the differential diagnoses of parkinsonism].
    Bech S; Haugbøl S; Winge K
    Ugeskr Laeger; 2017 Aug; 179(33):. PubMed ID: 28869013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential diagnosis of Parkinson's disease and atypical parkinsonian disorders by magnetic resonance imaging.
    Savoiardo M
    Neurol Sci; 2003 May; 24 Suppl 1():S35-7. PubMed ID: 12774211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using the presence of visual hallucinations to differentiate Parkinson's disease from atypical parkinsonism.
    Williams DR; Warren JD; Lees AJ
    J Neurol Neurosurg Psychiatry; 2008 Jun; 79(6):652-5. PubMed ID: 17872984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.
    Liscic RM; Srulijes K; Gröger A; Maetzler W; Berg D
    Acta Neurol Scand; 2013 May; 127(5):362-70. PubMed ID: 23406296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Atypical Parkinson syndromes--recent advances in diagnosis and therapy].
    Duerr S; Wenning GK; Seppi K; Poewe W
    Fortschr Neurol Psychiatr; 2012 Sep; 80(9):492-500. PubMed ID: 22457226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffusion tensor imaging differentiates vascular parkinsonism from parkinsonian syndromes of degenerative origin in elderly subjects.
    Deverdun J; Menjot de Champfleur S; Cabello-Aguilar S; Maury F; Molino F; Charif M; Leboucq N; Ayrignac X; Labauge P; Bonafe A; Castelnovo G; Le Bars E; Geny C; Menjot de Champfleur N
    Eur J Radiol; 2014 Nov; 83(11):2074-9. PubMed ID: 25154005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnostic criteria for Parkinson syndromes, expecting Parkinson's disease].
    Vidailhet M
    Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():43-50. PubMed ID: 10916036
    [No Abstract]   [Full Text] [Related]  

  • 29. An Autopsy Case of Progressive Supranuclear Palsy With Incidental ATXN2 Expansion.
    Kim A; Park SH; Jeon B
    JAMA Neurol; 2018 Aug; 75(8):1025-1027. PubMed ID: 29801076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 2.
    Booth TC; Nathan M; Waldman AD; Quigley AM; Schapira AH; Buscombe J
    AJNR Am J Neuroradiol; 2015 Feb; 36(2):236-44. PubMed ID: 24924549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parkinsonism.
    Keener AM; Bordelon YM
    Semin Neurol; 2016 Aug; 36(4):330-4. PubMed ID: 27643900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.
    Hellwig S; Amtage F; Kreft A; Buchert R; Winz OH; Vach W; Spehl TS; Rijntjes M; Hellwig B; Weiller C; Winkler C; Weber WA; Tüscher O; Meyer PT
    Neurology; 2012 Sep; 79(13):1314-22. PubMed ID: 22914831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive testing in the diagnosis of parkinsonian disorders: a critical appraisal of the literature.
    Lee W; Williams DR; Storey E
    Mov Disord; 2012 Sep; 27(10):1243-54. PubMed ID: 22890580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Milestones in atypical and secondary Parkinsonisms.
    Wenning GK; Litvan I; Tolosa E
    Mov Disord; 2011 May; 26(6):1083-95. PubMed ID: 21626553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroimaging in Parkinsonism: a study with magnetic resonance and spectroscopy as tools in the differential diagnosis.
    Vasconcellos LF; Novis SA; Moreira DM; Rosso AL; Leite AC
    Arq Neuropsiquiatr; 2009 Mar; 67(1):1-6. PubMed ID: 19330200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PET and SPECT functional imaging in Parkinson's disease.
    Antonini A; DeNotaris R
    Sleep Med; 2004 Mar; 5(2):201-6. PubMed ID: 15033144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Receiver operating characteristic analysis of sphincter electromyography for parkinsonian syndrome.
    Yamamoto T; Sakakibara R; Uchiyama T; Yamaguchi C; Nomura F; Ito T; Yanagisawa M; Yano M; Awa Y; Yamanishi T; Hattori T; Kuwabara S
    Neurourol Urodyn; 2012 Sep; 31(7):1128-34. PubMed ID: 22473520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients.
    Koga S; Aoki N; Uitti RJ; van Gerpen JA; Cheshire WP; Josephs KA; Wszolek ZK; Langston JW; Dickson DW
    Neurology; 2015 Aug; 85(5):404-12. PubMed ID: 26138942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "Atypical" atypical parkinsonism: new genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy-a diagnostic guide.
    Stamelou M; Quinn NP; Bhatia KP
    Mov Disord; 2013 Aug; 28(9):1184-99. PubMed ID: 23720239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Olfactory dysfunction in parkinsonian syndromes. Its role in early and differential diagnosis].
    Herting B
    Fortschr Neurol Psychiatr; 2010 Aug; 78(8):483-9; quiz 490-3. PubMed ID: 20694943
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.